Neoadjuvant Therapy for Pancreatic Cancer
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 12 (9) , 1600-1608
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinomaAnnals of Oncology, 2007
- Multimodality therapy for pancreatic cancer in the U.S.Cancer, 2007
- Phase II Trial of Infusional Fluorouracil, Leucovorin, Mitomycin, and Dipyridamole in Locally Advanced Unresectable Pancreatic Adenocarcinoma: SWOG S9700Journal of Clinical Oncology, 2007
- Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)BMC Cancer, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Docetaxel/Gemcitabine Followed by Gemcitabine and External Beam Radiotherapy in Patients With Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2005
- Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986–2003Surgical Oncology Clinics of North America, 2004
- Neoadjuvant therapy for pancreatic cancer: the Duke experienceSurgical Oncology Clinics of North America, 2004
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the PancreasAnnals of Surgical Oncology, 2001